BioNTech

• 3 Pfizer COVID-19 shots protect kids under 5, company says

  Preliminary data suggested the three-dose series is 80 per cent effective in preventing symptomatic COVID-19, Pfizer and its partner BioNTech said.

  Health

  May 23, 2022
  
• COVID-19: MLHU offering choice of Pfizer, Moderna vaccine at all its clinics

  The Middlesex-London Health Unit is hoping the ability to choose between the Pfizer and Moderna COVID-19 vaccines will help increase vaccine uptake.

  Health

  Feb 10, 2022
  
• Advertisement
• Pfizer says pandemic could last until 2024 as it tests 3-dose vaccine course for kids

  Pfizer Inc. said it is testing a three-dose course of the COVID-19 vaccine in all age groups under 16, including two to four-year-olds.

  Health

  Dec 17, 2021
• Advertisement
• Hong Kong panel advises 1 dose of BioNTech COVID-19 vaccine for teens due to side effect

  The advice was due to reports of heart inflammation as a possible side effect of the shot, which a health advisory committee said is more prevalent than originally thought.

  Health

  Sep 15, 2021
• 3rd dose of established COVID-19 vaccine best way to fight Delta variant: BioNTech

  The German biotech firm said a third dose of its established two-shot vaccine remained the best response to concerns over waning immune protection in the face of the Delta variant.

  Health

  Aug 9, 2021
• BioNTech vaccine should be up to 75% effective against India COVID-19 variant: CEO

  Since the concerning COVID-19 variant, known as B.1.617.2, was first identified in India, it has ravaged that country.

  Health

  May 20, 2021
• Pfizer asks U.S. FDA for full approval of COVID-19 vaccine

  If approved, the vaccine will be the first fully approved COVID-19 shot in the U.S. and could help ease vaccine hesitancy due to longer-term data required for an FDA approval.

  World

  May 7, 2021
• Pfizer-BioNTech could test vaccine on kids as young as 6 months by September

  Earlier this month, BioNTech and Pfizer asked U.S. regulators to approve emergency use of their COVID-19 vaccine for adolescents aged 12 to 15.

  World

  Apr 29, 2021
• Advertisement
• Europe will reach herd immunity this summer, BioNTech CEO says

  Europe can achieve herd immunity against the coronavirus within the next four months, the head of German pharmaceutical company BioNTech said.

  World

  Apr 28, 2021
• Advertisement
• Made-in-Canada vaccines: Canada injects millions in future Sanofi plant

  The project is being touted as an important addition to Canada's future pandemic preparedness.

  Canada

  Mar 31, 2021